17-AAG

27027

17-AAG

17-AAG binds specifically to heat shock protein Hsp90 in a manner similar to geldanamycin, but the binding is weaker. Inhibits Akt activation and HER2 expression in tumor cells. Exhibits 100-fold higher binding affinity for tumor-cell-derived hsp90 over that derived from normal cells. Inhibits angiogenesis.

435 €

1774-1

17-AAG

513.6 €

1774-5

17-AAG

1208.4 €

MBS132219-500mg

17 AAG (Tanespimyciin)

3723.12 €

MBS651558-250mg

17-AAG (17-allylamino-17-demethoxygeldanamycin, Telatinib, Tanespimycin, NSC-330507, CNF-101, KOS-953, GLD-36, CP 127374)

816.12 €

MBS651558-5x250mg

17-AAG (17-allylamino-17-demethoxygeldanamycin, Telatinib, Tanespimycin, NSC-330507, CNF-101, KOS-953, GLD-36, CP 127374)

2830.62 €